Prevention of chronic kidney disease: a global challenge.
In view of the increasing number of patients requiring renal replacement therapy (RRT) every year worldwide, attention has focused over the last two decades on meeting the health care need of patients with end-stage renal failure (ESRF). More recently, increasing awareness of the growing burden of chronic kidney disease (CKD), with a large percentage of the population affected by early stages of CKD, has shifted attention and health care priority to the prevention and early detection of CKD. This article addresses issues related to general population as well as targeted screening, favoring the latter. It also examines some of the screening initiatives undertaken in both the developing and developed worlds. It also highlights the links between albuminuria, CKD, and cardiovascular disease (CVD) as an increasing number of studies identify albuminuria/proteinuria, as well as CKD as major markers of CVD. Finally, a brief review is included of primary and secondary intervention strategies for CKD and issues related to their implementation: manpower and funding.
Bello
Aminu K
AK
Sheffield Kidney Institute, UK.
Nwankwo
Emeka
E
El Nahas
A Meguid
AM
D000419:Albuminuria / Q000175:diagnosis; D001315:Australia; D002318:Cardiovascular Diseases / Q000209:etiology; D003430:Cross-Sectional Studies; D005060:Europe; D005260:Female; D014943:Global Health; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000517:prevention & control*; D008297:Male; D008403:Mass Screening; D012307:Risk Factors; D014481:United States